Establishment of an animal model for pulmonary fibrosis in mice using monocrotaline.
A preliminary attempt at experimental induction of pulmonary fibrosis in which male ICR mice received 15 weekly sc injections of 200 or 100 mg/kg monocrotaline (MC) revealed that most animals treated with the larger dose died of severe interstitial pneumonia, whereas those given 100 mg/kg exhibited only relatively slight lung injury. Based on these results, male mice were administered sc injections of 200 and 100 mg/kg MC once a week for 9 and 18 times, respectively, and then maintained without any further treatment until week 28 after the start. Mice treated with 200 mg/kg MC showed severe pulmonary damage and died by week 25. Mortalities also occurred in the 100-mg group from week 16, with 11 of 40 animals surviving at the termination of the experiment. Histologically, both dose groups demonstrated severe interstitial pneumonia and/or pulmonary fibrosis. Ultrastructurally, inflammatory edema possibly attributable to injuries of alveolar capillary endothelial cells was observed in the high-dose group at week 8, and there was a remarkable increase in collagen fibers in alveolar septa in this group thereafter. The present study results suggest that lung injuries induced by MC treatment progress to irreversible lung fibrosis and that this animal model may have advantage for studying the pathogenesis of lung cancers in patients with pulmonary fibrosis.
Hayashi
S
S
Division of Pathology, National Institute of Health Sciences, Tokyo, Japan.
Mitsumori
K
K
Imaida
K
K
Imazawa
T
T
Yasuhara
K
K
Uneyama
C
C
Hayashi
Y
Y
D000818:Animals; D001835:Body Weight; D004195:Disease Models, Animal; D008168:Lung / Q000473:pathology*; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D016686:Monocrotaline / Q000008:administration & dosage / Q000633:toxicity*; D009929:Organ Size; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000473:pathology; D011897:Random Allocation
D016686:Monocrotaline